Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02711592 · ClinicalTrials.gov registry record · NA
Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study
A NA study, sponsored by TriHealth.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02711592 is a NA study that was terminated before completion, run by TriHealth. The registered enrollment target is 4 participants.
The verdict
NCT02711592, a NA study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The objective of this study is to see how pain management and its outcomes are effected when pharmacogenomic testing is used to determine patient specific pain medication and dosing. Our goal is to determine if through the use of analgesic genetic testing, TKA post-operative patients will see a decrease in narcotic consumption, postsurgical opioid- related adverse reactions, and length of stay, overall NRS pain scores and while maintaining or improving their satisfaction scores.
Interventions
- GENETIC Genetic Panel for Analgesics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-10-05 |
| Est. Completion | 2019-08-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02711592
The ClinicalTrials.gov registry entry for NCT02711592 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic Panel for Analgesics is the first listed.
NCT02711592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02711592 about?
NCT02711592 is a clinical study titled "Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study". The objective of this study is to see how pain management and its outcomes are effected when pharmacogenomic testing is used to determine patient specific pain medication and dosing. Our goal is to determine if through the use of analgesic genetic testing, TKA post-operative patients will see a decr...
What is the current status of trial NCT02711592?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-10-05. Estimated completion is 2019-08-22.
What interventions are being tested in trial NCT02711592?
The interventions under investigation include: Genetic Panel for Analgesics (GENETIC).
Who is sponsoring clinical trial NCT02711592?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.